Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy is the brand-name injectable form of semaglutide approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related conditions. However, many patients face insurance denials, prior authorization delays, or find the brand-name price prohibitive—even with coverage. PlexusDx offers an accessible alternative through licensed compounding pharmacies.

How Doctors Decide to Prescribe Wegovy for Weight Loss

Your primary care physician or weight loss specialist evaluates several factors before prescribing Wegovy. These include your body mass index (BMI), any weight-related health conditions such as type 2 diabetes or hypertension, previous weight loss attempts, and medication history. FDA approval criteria require a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. Your doctor will also screen for personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN2), as semaglutide carries a black-box warning for these populations.

The prescription process typically begins with a comprehensive visit where your doctor documents your weight loss goals and medical necessity. Insurance companies often require evidence of lifestyle modification attempts before approving Wegovy, and some plans deny coverage entirely. Even when approved, copays can exceed $200 per month. Many patients discover that their insurance requires step therapy, meaning they must try and fail cheaper medications first. This gatekeeping process can delay access to an effective treatment by months, during which weight gain may continue.

Semaglutide Injections: The Active Ingredient Behind Wegovy

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that signals your brain to reduce appetite and increase feelings of fullness. The medication slows gastric emptying, meaning food stays in your stomach longer, which extends satiety between meals. Clinical trials show that patients on semaglutide lose 10–15% of body weight over 68 weeks, compared to 3% in the placebo group. This mechanism works regardless of whether the semaglutide comes from Wegovy (the brand), a compounded injectable form, or other authorized sources—the molecular structure is identical.

PlexusDx partners with licensed 503A compounding pharmacies to prepare semaglutide injections tailored to individual dose schedules. Compounded semaglutide starts at $149 per month, with no flat per-compound pricing increases—your dose may need to go up as your body adjusts, but your price remains flat across all three commitment tiers. This transparency stands in stark contrast to brand-name Wegovy, where monthly costs typically range from $900 to $1,350 before insurance. No insurance approval, prior authorization, or membership fees are required to start treatment with PlexusDx.

Insurance Coverage Challenges and Alternatives

Insurance denials remain a major barrier to Wegovy access. Many plans classify weight loss medications as cosmetic rather than medical, or impose strict criteria that exclude patients who would benefit clinically. Even Medicare and Medicaid coverage varies by state and plan type. When coverage is approved, copays and deductibles can make brand-name therapy unaffordable. Prior authorization delays can stretch 4–8 weeks, prolonging the wait for patients ready to begin treatment. Some insurers require documented failure on other medications, further delaying care.

Compounded semaglutide bypasses insurance entirely, offering immediate access without prior authorization or eligibility disputes. PlexusDx serves all 50 states and accepts HSA and FSA funds, providing tax-advantaged payment options for eligible customers. The initial prescription can be issued during a telehealth consultation, and medication ships within days. For patients seeking personalized dosing based on genetic factors, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month), which maps 14 metabolic pathways and 49 peptides to identify how your body processes GLP-1 compounds and predicts optimal therapeutic response.

What to Discuss With Your Doctor About Semaglutide Therapy

If your doctor hesitates to prescribe Wegovy due to insurance barriers or cost, bring a conversation starter: ask whether compounded semaglutide from a licensed 503A pharmacy is a viable option. Many physicians are familiar with compounding and may be willing to write a prescription for this lower-cost alternative. Discuss baseline screening for thyroid nodules, personal or family history of medullary thyroid carcinoma, and your ability to monitor for potential side effects such as nausea, vomiting, or dehydration. Your doctor should also confirm that you are not pregnant and have no contraindications such as severe kidney or liver disease.

Bring your medical records, current medication list, and information about PlexusDx's licensed pharmacy partners and transparent pricing. Many patients find that their doctor is relieved to have a compliant, affordable option that removes insurance hassle. If your current provider is unwilling to prescribe, PlexusDx also connects patients with network physicians who specialize in weight loss and GLP-1 therapy. Whether you pursue Wegovy through traditional insurance or compounded semaglutide through PlexusDx, the critical step is starting treatment—delay increases the risk of continued weight gain and worsening metabolic health.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Why would my doctor refuse to prescribe Wegovy if I meet the BMI criteria?

Insurance requirements, patient age, kidney function, or personal risk factors like thyroid cancer history may influence your doctor's decision. Cost concerns and prior authorization delays also discourage some practices from prescribing. If your doctor declines, ask about compounded semaglutide as an alternative—many physicians will prescribe it when insurance is removed from the equation.

Is compounded semaglutide as effective as Wegovy?

Yes. Both contain identical semaglutide molecules prepared under strict pharmaceutical standards. PlexusDx sources from licensed 503A compounding pharmacies, which follow FDA oversight and USP standards. Clinical outcomes depend on dose adherence and individual physiology, not brand name—expect similar 10–15% weight loss over 68 weeks with either form.

How much will semaglutide cost me through PlexusDx versus Wegovy?

PlexusDx compounded semaglutide injections start at $149 per month with no flat per-compound pricing increases. Wegovy typically costs $900–$1,350 monthly before insurance, and copays often exceed $200 even with coverage. PlexusDx accepts HSA/FSA funds and requires no insurance or membership fees.

What side effects should I expect, and are they different between Wegovy and compounded semaglutide?

Common side effects include nausea, vomiting, diarrhea, and constipation—most mild and temporary during dose escalation. Rare serious effects include pancreatitis and severe dehydration. Side effects are identical regardless of brand because the active compound is the same. Your doctor will monitor your tolerance and adjust dosing as needed.

How does the Precision Peptide Genetic Test help me optimize my semaglutide therapy?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R pathways to predict how your body responds to GLP-1 compounds. Results guide personalized dosing and identify whether you may benefit from combination therapies, maximizing your weight loss outcome.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves